news room

Bon Secours Cancer Institute Physicians Co-Author Chapter for International Oncology Text

Chapter can be found in 10th Edition of the prestigious Cancer: Principles & Practice of Oncology

Norfolk, Va. (June 10, 2014) – Bon Secours Cancer Institute executive medical director and surgical oncologist Itzhak Avital, M.D., and colleagues have authored a chapter to be included in one of the most prestigious cancer textbooks in the world. 

Dr. Avital is joined by colleagues and co-authors, Alexander Stojadinovic, M.D., medical director, Bon Secours Cancer Institute, Peter W.T. Pisters, M.D., department of surgery, MD Anderson Cancer Center, David P. Kelsen, M.D., medical oncologist, Memorial Sloan Kettering Cancer Center, and Christopher G. Willett, M.D., professor of radiation oncology, Duke Cancer Center; who together wrote the chapter Cancer of the Stomach, for the 10th Edition of Cancer: Principles & Practice of Oncology, a text accepted worldwide as a definitive reference and source for cancer information.

Cancer: Principles & Practice of Oncology, edited by Vincent T. DeVita Jr., M.D., Theodore S. Lawrence, M.D., Ph.D., and Steven A. Rosenberg, M.D., Ph.D., is designed to present practicing oncologists with practical and cutting-edge information available to ensure the best possible care for patients.

Dr. Avital, the chapter’s lead author, is known internationally for his work in the field of gastric oncology, in particular. His many achievements include the groundbreaking discovery of a new form of familial gastric cancer, Proximal Polyposis Familial Gastric Cancer Syndrome, and the establishment of the National Cancer Institute IRB’s first set of standards for using WGS (whole genome DNA sequencing) in clinical protocols for familial cancers. Dr. Avital served as lead researcher on the first team to utilize WGS to identify the culprit gene in familial cancer. He also developed and led the research for the clinical trial, Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy plus Systemic Therapy vs. Systemic Therapy Alone: GYMSSA Trial, in patients with metastatic gastric cancer. 

“Dr. Avital has made both meaningful and groundbreaking pathways with regards to cancer care and treatment,” said Alexander Stojadinovic, M.D., medical director, Bon Secours Cancer Institute and co-author of the chapter. “Our Bon Secours team is grateful for his leadership and for the extraordinary care he provides our patients. Partnering with him on this prestigious opportunity has been an exceptional experience.” 

Dr. Avital joined Bon Secours Cancer Institute as executive medical director in 2012. Prior to joining Bon Secours, he served as division head of the GI and HPB malignancies section of the National Cancer Institute (NCI) and the National Institutes of Health (NIH) in Bethesda, Md. Dr. Stojadinovic joined Bon Secours in late 2012, following his tenure at the Uniformed Services University of the Health Sciences in Bethesda, Md., where he remains a professor of surgery and medicine. 

“This book has long been a staple of the medical oncologist’s library, and we are honored to be part of such a profound and internationally recognized source for oncologists, and to have partnered with our colleague oncologists, some of the top minds in our field today,” said Dr. Avital.    

The Bon Secours Cancer Institute team members combine the science to cure with the art of compassion. World-class surgical, medical and radiation oncology experts, certified oncology nurses, and support staff collaborate to offer the latest and most effective inpatient and outpatient cancer treatments. 

 

back to news listings

news & media

twitter feed

Bon Secours International| Sisters of Bon Secours USA| Bon Secours Health System